1. Introduction {#sec0005}
===============

The avian coronavirus infectious bronchitis virus (IBV) is an important viral pathogen for the poultry industry worldwide ([@bib0115]). IBV is an enveloped, positive strand RNA virus belonging to the genus *Gammacoronavirus*, family *Coronaviridae*, order *Nidovirales* ([@bib0010]). The prototype IBV strain Massachusetts 41 (M41) causes a highly contagious respiratory infection in chickens, while the pathology of other IBV strains ranges from mild respiratory symptoms to diseases affecting mainly oviduct and kidney, sometimes resulting in the death of the animal (reviewed in [@bib0190]).

Coronaviruses have a strict species tropism, which is largely determined by the interaction of the viral attachment protein spike (S) with the host cell (recently reviewed in [@bib0035], [@bib0095]). The coronaviral S protein is a highly glycosylated class I viral fusion protein ([@bib0040]), which in some coronaviruses, including IBV, is cleaved during synthesis into an S1 and an S2 subunit by the host serine protease furin ([@bib0075], [@bib0225]). The S1 is essential for initial attachment of the virus, while the membrane anchored S2 subunit or domain, containing the remaining part of the ectodomain, a transmembrane domain and an endodomain, drives virus-cell fusion (reviewed in [@bib0105]). All coronaviral receptor-binding domains (RBD) currently identified are located within the S1 subunit or domain (reviewed in [@bib0035], [@bib0095]). For IBV, the exact location of the RBD has, however, not yet been elucidated. Heterogeneity between IBV strains is mainly associated with differences in S1, but IBV spike cleavage (into an approximately 520 amino acid (aa) S1 and an approximately 620 aa S2 subunit [@bib0055]) appears to be independent of geographical origin, serotype or the pathogenic profile ([@bib0120]). Ultimately, the host and tissue range of coronaviruses is determined by the expression of specific receptors. Specific protein receptors have been identified for many alpha- and betacoronaviruses ([@bib0035], [@bib0095] and references therein). For avian gammacoronaviruses, no such protein receptor has been elucidated, but alpha-2,3 linked sialic acids have been shown to be essential for attachment and subsequent infection of avian cells ([@bib0005], [@bib0210], [@bib0220], [@bib0215]). In addition, it was recently demonstrated that expression of human DC-SIGN-like lectins renders cells susceptible to IBV infection ([@bib0235]), but no avian counterpart of this molecule has yet been identified. Thus, the molecular determinants for the host and tissue range of IBV are yet far from understood.

Most clinical IBV strains can only be replicated in embryonated eggs or primary chicken embryonic kidney cells upon adaptation to these systems ([@bib0060], [@bib0125], [@bib0160]). The best studied avian coronavirus strain, IBV Beaudette, however, has the ability to infect cultured cell lines, including the mammalian cell lines Vero and BHK-21 ([@bib0085], [@bib0150]). Beaudette was derived from the Massachusetts strain M41 by serial passage in embryonated eggs for at least 150 times ([@bib0250]), rendering the virus highly pathogenic for chicken embryos, but avirulent for chickens ([@bib0090]). M41 and Beaudette have 96% amino acid identity in their spikes, with 25 aa differences in S1 (excluding the signal sequence) and 18 aa changes in S2. The essential role of the spike in determining the extended host range of IBV Beaudette was shown upon exchange of spike genes in the recombinant Beaudette viral genome. Substitution of the spike protein of M41 ([@bib0050], [@bib0110]) or 4/91 ([@bib0015]) into the Beaudette genome abolished the ability of Beaudette to infect mammalian cell lines, but did not confer pathogenicity in chickens ([@bib0015], [@bib0110]).

Previously, we showed that the S1 protein of the embryo- and cell culture-adapted Beaudette, in contrast to that of the virulent M41, is not able to bind to chicken respiratory tract tissues ([@bib0210]). While the observed difference was in line with the reported changes in the ability of these two virus strains to infect and replicate in chickens, the results were to some extent unexpected. IBV Beaudette can be propagated in trachea organ cultures (TOCs; [@bib0060]) and embryonated eggs (reviewed in [@bib0100]), and has extended tropism for mammalian cells ([@bib0065], [@bib0150]), but its requirements for attachment and subsequent entry are still under debate. While heparan sulfate (HS) binding was proposed to be required for its extended tropism ([@bib0135]), studies with recombinant Beaudette indicate that the proposed HS binding site in S2 is not crucial for entry of the virus ([@bib0225]). Here, we aimed at further elucidating the requirements for IBV Beaudette spike attachment using our recently developed spike histochemistry assay ([@bib0210]). Particular focus was on the contribution of the S2 part of the ectodomain of the spike. Our results show that the complete ectodomain was required to confer binding of the Beaudette spike to chicken tissues. Host sialic acids, but not HS, were required for the attachment. Analysis of the spike ectodomain of M41 and chimeric spikes suggests that the IBV S2 ectodomain does not contain an additional independent binding site, but rather increases the avidity of S1. Interestingly, ectodomains comprised of only Beaudette spike sequences had the ability to bind to mammalian cell cultures, suggesting that both S1 and S2 contain determinants important for the extended host range of Beaudette.

2. Materials and Methods {#sec0010}
========================

2.1. Cells and cell culture pellets {#sec0015}
-----------------------------------

Human Embryonic Kidney (HEK) 293T cells, Vero-CCL81 and BHK21 were maintained in Dulbecco\'s Modified Eagle Medium (DMEM) (BioWhittaker) supplemented with 2% glutamine, 10% Fetal Calf Serum (FCS) (BioWhittaker) and 0.1 mg/ml gentamicin (Gibco Invitrogen). Chicken fibroblast DF1 cells were cultured in DMEM supplemented with 2% glutamine, 0.1 mg/ml gentamicin, 10% FCS and 1% sodium pyruvate (Sigma--Aldrich). To obtain cell pellets for spike histochemistry, cells from monolayers of Vero-CCL81 and BHK21 were collected by scraping and subsequent centrifugation at 200 ×  *g*. Pellets were fixed in formalin for 24 h and embedded in paraffin.

2.2. Virus stocks and inoculation of embryonated chicken eggs {#sec0020}
-------------------------------------------------------------

The allantoic cavity of 11-day-old SPF embryonated chicken eggs (ECE) were inoculated with 200 EID~50~ of the IBV strains M41 and Beaudette (Animal Health Service, Deventer, The Netherlands). Inoculated ECE were candled twice daily and at 48 h post-inoculation chorio-allantoic membranes (CAM) were fixed in formalin for 24 h prior to paraffin-embedding of the tissue.

2.3. Anti-IBV immunohistochemistry {#sec0025}
----------------------------------

Formalin-fixed, paraffin-embedded 4-5 μm sections of CAM were mounted on glass slides and subsequently deparaffinized and rehydrated in alcohol series. Next, the sections were subjected to endogenous peroxidase inactivation by incubating slides in 1% hydrogen peroxide in methanol for 30 min at room temperature (RT). Antigen retrieval was performed by boiling the slides for 10 min in preheated 10 mM Tris-EDTA at pH 9.0. Wash buffer was composed of 1× Normal Antibody Diluent (ScyTek Laboratories, USA) containing 0.1% Tween-20. IBV antigens were detected by incubating the tissue sections at RT for 60 min with nucleocapsid protein-specific mouse monoclonal antibody (1:100 dilution; clone Ch/IBV 48.4; Prionics, The Netherlands). Antibody binding was detected by Dako Envision HRPO labeled polymer anti-mouse (Dako, USA). The staining was visualized by 3,3′-diaminobenzidine (DAB). Slides were counterstained with Hematoxylin and mounted with Eukitt^®^ (Kindler, Germany). The presence of viral antigens was assessed by light microscopy and captured using a charge-coupled device (CCD) camera and an Olympus BX41 microscope linked to Cell\^B imaging software (Soft Imaging Solutions GmbH, Germany).

2.4. Genes and expression vectors {#sec0030}
---------------------------------

Sequences of IBV-M41 (accession number [AY851295](ncbi-n:AY851295){#intr0010}) and -Beaudette CK (accession number [AJ311317](ncbi-n:AJ311317){#intr0015}) were obtained from the National Center for Biotechnology Information (NCBI) GenBank (<http://www.ncbi.nlm.nih.gov/genbank/>). Expression vectors encoding codon-optimized S1 genes of M41 (M.S1) or Beaudette (B.S1) were previously described ([@bib0210]). Sequences encoding the S2 ectodomain part of the spike (comprising aa 539 to 1091 for both M41 and Beaudette) were codon-optimized for human expression and synthesized (Genscript, Piscataway, NJ, USA). At the S1/S2 border, the furin cleavage site sequence RRFRR was replaced by GGGVP, allowing the production of full length S ectodomains. The codon-optimized S2 sequences were subsequently cloned into the pCD5 vector containing the S1 domain of M41 or Beaudette using *Kpn*I and *Pac*I restriction enzymes, generating pCD5-B.ED and pCD5-M.ED. The S ectodomain genes were preceded by an N-terminal CD5 signal sequence and followed by sequences coding for a C-terminal artificial GCN4 trimerization motif and Strep-tag II for detection and purification of proteins, as described before ([@bib0210]). In addition, we generated two B.ED mutants, one in which the sequence encoding the second furin cleavage site SRRKR/S was mutated into a sequence predicted not to be cleaved ([Table 1](#tbl0005){ref-type="table"} ), but composed of the heparin-binding consensus SHRKHS (aa 686--691), resulting in B.ED^\*cl^, and one in which this site was replaced with the corresponding sequence of M41 SPRRRS, resulting in B.ED^\*M41^ ([Table 1](#tbl0005){ref-type="table"}). Expression vectors encoding chimeric S ectodomains were generated by cloning the S2 domains into the pCD5-S1 encoding plasmids with the reciprocal strain using *Kpn*I and *Pac*I restriction enzymes, for expression of proteins B.S1-M.S2 and M.S1-B.S2 ([Table 1](#tbl0005){ref-type="table"}).Table 1Overview of the IBV spike constructs and their characteristics.AbbreviationDescriptionSchematic outlineSequence aa 533--538ProP score S1/S2Sequence aa 686--691ProP score 2ndBeaudette full length spike protein![](fx1.gif)RRFRR/S0.779SRRKR/S0.833M41 full length spike protein![](fx2.gif)RRFRR/S0.779SPRRRS0.331B.S1Beaudette S1![](fx3.gif)Not present×Not present×M.S1M41 S1![](fx4.gif)Not present×Not present×B.EDBeaudette ectodomain![](fx5.gif)GGGVPS0SRRKR/S0.833B.ED^\*cl^Beaudette ectodomain; 2nd furin cleavage site knockout![](fx6.gif)GGGVPS0SHRKHS0.102B.ED^\*M41^Beaudette ectodomain; 2nd cleavage site mutation M41![](fx7.gif)GGGVPS0SPRRRS0.331M.EDM41 ectodomain![](fx8.gif)GGGVPS0SPRRRS0.331M.S1-B.S2^\*cl^M41 S1 -- Beaudette S2; 2nd furin cleavage site knockout![](fx9.gif)GGGVPS0SHRKHS0.102B.S1-M.S2Beaudette S1 -- M41 S2![](fx10.gif)GGGVPS0SPRRRS0.331[^1][^2][^3]

2.5. Production of recombinant spike proteins and purification {#sec0035}
--------------------------------------------------------------

Spike proteins were produced in mammalian HEK293T cells as described before ([@bib0210]). For spike protein production from avian cells, chicken fibroblast DF1 cells at 60% confluence were transfected with pCD5-B.S1 or pCD5-M.S1 using NanoJuice (Novagen). To this end, NanoJuice Reagent and Booster were mixed in 1:1 ratio (5 μl each per 35 cm^2^ culture surface area) before adding them to pre-warmed DMEM and incubation for 5 min at RT. Plasmid DNA (3.5 μg per 35 cm^2^ culture surface area) was added and incubated at RT for 15 min before adding it onto DF1 cells. After 24 h transfection, the transfection mixture was replaced by expression medium, as described for HEK293T cells ([@bib0210]). The supernatants were harvested 9 days post-transfection, and the proteins were purified using Strep-Tactin Sepharose beads according to the manufacturer\'s protocols (IBA GmbH). The protein concentrations were determined by Qubit^®^ 2.0 fluorometer (Invitrogen).

2.6. Western blot and PNGaseF treatment {#sec0040}
---------------------------------------

The expression and purification of the IBV spike proteins were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blotting using horseradish peroxidase (HRPO)-conjugated Strep-Tactin (IBA GmbH). Where indicated, the spike proteins were treated with N-glycosidase F (PNGase F; New England Biolabs Inc.) prior to electrophoresis according to the manufacturer\'s procedures to remove oligosaccharide side chains.

2.7. Prediction of cleavage by furin {#sec0045}
------------------------------------

To predict cleavage at the proposed second furin-type cleavage site, sequences were analyzed using the ProP 1.0 server (<http://www.cbs.dtu.dk/services/ProP/>). Prediction scores above 0.5 indicate that the residue is likely followed by an R-K propeptide cleavage site. The ProP scores for wild type and mutant sequences are shown in [Table 1](#tbl0005){ref-type="table"}.

2.8. Spike histochemistry, tissue treatment with soluble heparin and VCNA {#sec0050}
-------------------------------------------------------------------------

Sections (4--5 μm thick) of formalin-fixed, paraffin-embedded tissues from a 6-week-old male broiler chicken and an 11-day old SPF chicken embryo were used to study the binding of spike glycoproteins as described previously ([@bib0210]). To study the dependence of the binding of spike ectodomains on heparan sulfate and sialic acids, tissue slides were pre-incubated overnight with 1 and 10 mg/ml of soluble sodium heparin (Sigma--Aldrich, GmBH) at 4 °C, or with 1 mU neuraminidase from Vibrio cholera (VCNA) (Roche) at 37 °C, respectively, before performing spike histochemistry.

3. Results {#sec0055}
==========

3.1. Recombinant Beaudette S1 does not display detectable binding to virus-susceptible CAM tissue {#sec0060}
-------------------------------------------------------------------------------------------------

We confirmed our previous observations ([@bib0210]) that recombinant S1 protein of the embryo- and cell culture-adapted IBV strain Beaudette (B.S1) did not show binding to the chicken trachea in our spike histochemistry assay, while in contrast, the S1 of the virulent M41 strain (M.S1) displayed clear binding to the base of the cilia and goblet cells of the trachea ([Fig. 1](#fig0005){ref-type="fig"}A). To exclude that the lack of binding of B.S1 was due to the absence of appropriate receptors on this tissue, we next selected embryonic CAM tissues, reported to support infection and replication of both IBV Beaudette and M41. Indeed, after inoculating eggs on day 11 of embryonation with IBV-M41 or -Beaudette, viral antigens could readily be detected in both allantoic and chorionic epithelium of the CAM when stained with antibody for the nucleocapsid protein at 2 days post-inoculation ([Fig. 1](#fig0005){ref-type="fig"}B). As expected, Beaudette-infected embryos even displayed a higher number of infected cells than M41-infected embryos when using the same inoculation titer, due to the adaptation of Beaudette to embryos. Spike histochemistry performed on CAM sections of non-infected 11-day-old embryonated eggs showed, however, that B.S1 was not able to bind to these tissues, while M.S1 displayed clear binding to the allantoic membrane ([Fig. 1](#fig0005){ref-type="fig"}C). Taken together, these results suggest that the lack of binding of Beaudette S1 is not due to lack of attachment factors on the host tissue, but is rather an intrinsic feature of the recombinant Beaudette S1 protein.Fig. 1Spike and anti-IBV histochemistry on chicken tissues. Chicken trachea (A) and CAM derived from embryonated eggs (C) were used for spike histochemistry. Beaudette S1 (B.S1) and M41 S1 (M.S1) proteins (5 μg) expressed from HEK293T cells were applied to each tissue section and spike histochemistry was performed as described before ([@bib0210]); (B) immunohistochemistry using anti-IBV nucleocapsid monoclonal antibody 48.4 was performed on CAM isolated from embryonated eggs 2 days after inoculation with IBV Beaudette and M41 as described in Section [2](#sec0010){ref-type="sec"}.

3.2. Recombinant Beaudette S1 expressed from avian cells does not bind to CAM {#sec0065}
-----------------------------------------------------------------------------

Recombinant spike proteins used in our assay are produced in a well-established mammalian expression system in human HEK 293T cells. To exclude that the lack of binding of B.S1 to CAM and trachea is due to yet unrevealed differences in protein glycosylation between mammalian cells and the natural avian host, we next produced Beaudette S1 proteins from chicken DF1 cells. To this end, transfection conditions were optimized for this particular cell type and soluble proteins collected from the supernatant of these cells were purified ([@bib0210]) and analyzed by Western blot. Recombinant M.S1 and B.S1 produced in DF1 cells migrated with an electrophoretic mobility comparable to proteins produced in 293T cells ([Fig. 2](#fig0010){ref-type="fig"}A). Although differences in glycosylation cannot be excluded, S1 proteins produced in avian cells are, like those produced in human cells, highly glycosylated, as removal of the N-linked glycans with PNGaseF increased the electrophoretic mobility of all S1 proteins to around 70 kDa. Of note is that the amount of soluble protein produced in avian cells was repeatedly less than that produced in mammalian cells. This might be caused by the less robust expression of recombinant proteins in avian cells, or due to slight differences in preferred codon-usage of avian and mammalian cells.Fig. 2Expression of recombinant IBV S1 proteins produced in mammalian and chicken cells and spike histochemistry on chicken tissues. (A) S1 proteins expressed in human HEK293T and chicken DF1 cells were purified from the culture media. The proteins were analyzed by SDS-PAGE followed by Western blot using Strep-Tactin; when indicated the samples were treated with PNGaseF prior to electrophoresis; (B) spike histochemistry on CAM tissue using similar amounts of each of the S1 proteins.

Spike histochemistry using similar amounts of recombinant proteins showed, however, no appreciable staining of the CAM when B.S1 produced in avian DF1 cells were applied. For M.S1 we observed that the level of binding of S1 proteins produced in avian cells was slightly less than that produced in mammalian cells ([Fig. 2](#fig0010){ref-type="fig"}B), for reasons that are currently unknown. Threefold increase in the amount of both mammalian and avian-produced B.S1 protein did not result in detectable binding to CAM (data not shown). Taken together, the previously observed lack of binding of B.S1 to CAM is likely not due to potential differences in glycosylation or other yet unrecognized differences between proteins produced in human and avian cells. Likely, other viral protein domains contribute to the binding of Beaudette to susceptible cells, by providing either an additional binding site or increasing the affinity of the S1 domain.

3.3. The S2 domain, but not HS binding site, is required for gain of binding of Beaudette spike to susceptible tissues {#sec0070}
----------------------------------------------------------------------------------------------------------------------

Currently, all evidence points toward a sole contribution for the viral glycoprotein spike in coronaviral attachment. While the S1 is generally assumed to contain the RBD, the C-terminal S2 domain might act in concert with S1 during entry and account for the extended host range, as was shown for a murine hepatitis virus (MHV) strain with extended tropism ([@bib0080]). In addition, the S2 of Beaudette has a heparin-binding consensus XBBBXXB sequence (where X is a hydropathic amino acid and B is a basic residue, as previously defined by [@bib0045]). This sequence has earlier been proposed to bind to HS on the cell surface and thereby be responsible for the extended tropism of Beaudette ([@bib0135]). To investigate the role of the Beaudette S2 domain in attachment, we extended our Beaudette S1-encoding constructs to now comprise the complete spike ectodomain, but lacking the non-exposed transmembrane and cytoplasmic domains. To be able to generate full-length soluble spike ectodomains, we decided to mutate the furin cleavage site (aa 533--538) in Beaudette spike from RRFRR/S to GGGVPS ([Table 1](#tbl0005){ref-type="table"}) as cleavage between S1 and S2 is not important for binding, but rather affects downstream events in the infection ([@bib0225]). In Beaudette S2, however, the putative HS-binding sequence overlaps with a second furin cleavage site (aa 686--691; SRRKR/S) ([@bib0225]). To allow to study the role of this sequence in binding we decided to generate two versions of the Beaudette spike ectodomain: one containing the wild type Beaudette sequence SRRRR/S at the secondary cleavage site (B.ED), and one in which this sequence was mutated to SHRKHS, resulting in loss of predicted furin cleavage ([Table 1](#tbl0005){ref-type="table"}, compare ProP scores), while retaining the heparin-binding consensus sequence (B.ED\*^cl^). Codon-optimized sequences were cloned into our expression vector such that they were again preceded with a CD5 signal sequence and followed by a trimerization domain and a Streptag for purification and analysis purposes. Recombinant proteins were expressed in 293T cells and analyzed by Western blot ([Fig. 3](#fig0015){ref-type="fig"}A). While for B.ED^\*cl^ one protein band migrating at approximately 200 kDa was observed, an additional protein band was observed for B.ED migrating at around 70 kDa. As detection is based on the presence of the Streptag, these proteins likely represent the full-length ectodomain and the C-terminal domain after furin cleavage, respectively. These results indicate that recombinantly produced Beaudette-ED is partially cleaved during production, while cleavage is abrogated in the mutant B.ED^\*cl^. PNGaseF treatment showed that the spike ectodomains migrate around the expected 130 kDa, confirming that these proteins are, as previously observed ([@bib0230]) and like the S1, highly glycosylated. For B.ED, the observed additional band after PNGaseF treatment migrating around 47 kDa corresponds with the expected size of the C-terminal domain with Streptag after furin cleavage.Fig. 3Expression of recombinant IBV Beaudette spike ectodomains and analysis of binding to CAM. (A) Soluble Beaudette spike ectodomains were produced in HEK293T cells, purified, and subsequently analyzed by Western blot using Strep-Tactin; when indicated the samples were treated with PNGaseF prior to electrophoresis; (B/C/D) Spike histochemistry was performed on CAM tissues using 9 μg Strep-Tactin-precomplexed B.ED and mutants thereof before (B and D) or after (C) pre-incubating the tissues with various concentrations of soluble heparin.

Next, we analyzed the ability of B.ED and B.ED\*^cl^ to bind to CAM tissue. Spike ectodomain was again precomplexed with Strep-Tactin, now using 9 μg of protein per slide (resulting in equimolar amounts of proteins as used for B.S1 in [Fig. 2](#fig0010){ref-type="fig"}). In spike histochemistry we observed that both B.ED and B.ED\*^cl^ stained the allantoic membrane of the CAM ([Fig. 3](#fig0015){ref-type="fig"}B), indicating that extension of S1 with sequences from the S2 ectodomain was sufficient to gain binding of the spike to susceptible tissues. It seems most likely that the full-length soluble ectodomains of B.ED and B.ED\*^cl^ are responsible for the ultimate binding to the tissue, although we cannot exclude a particular contribution of the smaller C-terminal domain if still complexed with full length ectodomains. To investigate whether the binding of these proteins was due to the presence of the HS binding site in S2, we blocked CAM tissues with soluble heparin before applying recombinant B.ED and B.ED^\*cl^ proteins. No reduction in binding was observed when applying either 1 or 10 mg/ml soluble heparin ([Fig. 3](#fig0015){ref-type="fig"}C), suggesting that HS binding is not required for binding of Beaudette spikes to susceptible tissues. To confirm this, we generated a mutant recombinant Beaudette spike ectodomain, in which the heparin consensus sequence was changed into the corresponding sequence of M41 at that position (aa 686--691, SPRRRS; [Table 1](#tbl0005){ref-type="table"}). The resulting protein, B.ED\*^M41^ lacking both the consensus HS binding site and the furin cleavage site was expressed from 293T cells as full length ectodomain ([Fig. 3](#fig0015){ref-type="fig"}B), and had the ability to bind to the allantoic epithelium of CAM tissues ([Fig. 3](#fig0015){ref-type="fig"}D). Interestingly, this mutant displayed even greater binding to the CAM; the reason for this remains unclear. In conclusion, the Beaudette S2 ectodomain, but not the proposed HS binding site, is required for attachment of spike to susceptible chicken tissues.

3.4. Binding of Beaudette spike ectodomain depends on sialic acids {#sec0075}
------------------------------------------------------------------

Previously, we showed that attachment of the S1 protein of M41 is dependent on alpha-2,3-linked sialic acids ([@bib0210]). In order to elucidate whether Beaudette spike ectodomain binding also relies on the interaction with sialic acids present on host cells, we pretreated the cells with Vibrio cholera neuraminidase (VCNA) before applying the spike proteins onto the tissues. As a control, we included M.S1 ([Fig. 4](#fig0020){ref-type="fig"} ). Spike histochemistry revealed that the binding of B.ED was completely lost after VCNA treatment, showing that also the Beaudette spike requires sialic acids for its attachment to the cell surface of susceptible cells. These results are in agreement with previous observations that sialic acids serve as receptor determinants for Beaudette on respiratory tract epithelium and primary chicken kidney cells ([@bib0005], [@bib0220], [@bib0215]).Fig. 4Binding of recombinant Beaudette ectodomain depends on sialic acids. CAM tissues were pretreated with PBS (-VCNA) or PBS with VCNA (+VCNA) prior to spike histochemistry.

3.5. The S2 domain likely does not contain an additional independent binding site, but rather contributes to the avidity of spike attachment {#sec0080}
--------------------------------------------------------------------------------------------------------------------------------------------

Whether the observed gain of binding of Beaudette spike is due to the presence of an additional receptor-binding domain in S2 or whether this region stabilizes the conformation of S1 resulting in increased avidity and thus detectable binding in our assay is unknown. To elucidate whether the S2 domain harbors an additional attachment site, we first separately cloned the S2 part of the ectodomain (aa 539--1091) of Beaudette in our expression vector, lacking S1. Unfortunately, no recombinant proteins could be detected in the cell culture supernatant of HEK293T cells transfected with the resulting plasmid (data not shown), suggesting that the S2 ectodomain could not fold independently from the S1 domain.

As an alternative approach to get a hint of the contribution of S1 and S2 in attachment, we generated chimeric spike ectodomain proteins, composed of the S1 domain of M41 and the S2 domain of Beaudette or the reciprocal. For proteins containing the S2 domain of Beaudette we used the BS2^\*cl^ sequence to prevent subsequent cleavage. As control proteins we produced soluble full length M41 (M.ED) and Beaudette (B.ED^\*cl^) ectodomains. The proteins were produced in 293T cells and Western blot analysis using Strep-Tactin showed that all proteins could be expressed and had the expected mobility in SDS-PAGE gel ([Fig. 5](#fig0025){ref-type="fig"}A). In spike histochemistry, M.ED interestingly displayed not only binding to the allantoic, but also to the chorionic membrane of the CAM ([Fig. 5](#fig0025){ref-type="fig"}B). In particular, the binding resembled the sites of replication of IBV in the CAM after infection most closely ([Fig. 1](#fig0005){ref-type="fig"}B). Again, the extended binding of M.ED compared to M.S1 ([Fig. 1](#fig0005){ref-type="fig"}C) could be due to the presence of an additional binding site in S2 or a concerted action between S1 and S2 thereby increasing the binding avidity. To address this, we analyzed the binding of our chimeric proteins to CAM. For B.S1-M.S2 we observed a binding pattern comparable to that of B.ED^\*cl^ ([Fig. 5](#fig0025){ref-type="fig"}B). More specifically, binding was observed to the allantoic epithelium of the CAM, but with rather low avidity. In addition, M.S1-B.S2^\*cl^ demonstrated slightly reduced binding compared to M.S1, suggesting that the gain of binding of Beaudette and the extended binding of M41 is probably not due to the presence of an additional receptor-binding site in S2. The presence of an additional binding site for glycans in M.S2 was excluded by glycan array analysis using M.ED, where we observed a similar preference for alpha-2,3-linked sialic acids as for M.S1 (data not shown). The observed increased affinity for these carbohydrate structures in glycan array was in line with the increased levels of binding in spike histochemistry.Fig. 5Expression of chimeric recombinant IBV spike ectodomains and analysis of binding to CAM. (A) Soluble spike ectodomains were produced in HEK293T cells, purified, and subsequently analyzed by Western blot using Strep-Tactin; (B/C) Spike histochemistry was performed on CAM (B) and chicken trachea (C) using 9 μg chimeric recombinant spike proteins precomplexed with Strep-Tactin. \* indicates the allantoic membrane; arrows indicate staining of the chorionic membrane.

Taken together, our data suggest that the presence of S2 increases the avidity of S1 resulting in detectable binding of these spikes to susceptible tissue. Although not required for binding to CAM per se, it seems that combinations of S1 and S2 originating from the same viral origin work best. This was confirmed when performing spike histochemistry on chicken trachea tissues ([Fig. 5](#fig0025){ref-type="fig"}C). M.ED displayed strong binding to both goblet cells and ciliated epithelium, but also B.ED^\*cl^ and B.ED (not shown) had the ability to bind to this tissue. In contrast to what was observed for CAM, the combination of B.S1 and M.S2 was not sufficient for binding to trachea ([Fig. 5](#fig0025){ref-type="fig"}C), suggesting that a concerted action between Beaudette S1 and S2 in combination with the presence of particular host surface molecules determines the range of attachment to tissues.

3.6. Beaudette spike ectodomain displays extended attachment for mammalian cell lines {#sec0085}
-------------------------------------------------------------------------------------

Finally, we elucidated whether the extended host range of IBV Beaudette, that is, its ability to infect mammalian cell cultures, is also reflected by the attachment pattern of the spike ED. To this end, we performed spike histochemistry on formalin-fixed, paraffin-embedded Vero-CCL81 and BHK-21 cells, known to be susceptible to Beaudette. Our results show that B.ED^\*cl^, but not M.ED, binds to the cell surface of these culture cells ([Fig. 6](#fig0030){ref-type="fig"}A). The rather limited signal of binding to culture cells compared to chicken tissues might be due to a lower expression of attachment factors on these cells, which likely reduces the sensitivity of the assay. B.S1 alone did not have the ability to bind to these cells ([Fig. 6](#fig0030){ref-type="fig"}B), nor the chimeric ED proteins with Beaudette S1 or S2 fused to M41 S2 or S1, respectively, even when using 5-fold higher protein concentration. Taken together, our results indicate that specific sequences present in both Beaudette S1 and S2 contribute to the mammalian cell tropism of Beaudette. Where these particular domains in these subunits are situated and how they both contribute to the extended host tropism will require further investigation.Fig. 6Binding of recombinant IBV spike ectodomains to mammalian cell cultures. Spike histochemistry was performed on pelleted cells of Vero-CCL81 and BHK-21 cultures using Strep-Tactin precomplexed spike ectodomains of Beaudette and M41 (A) and chimeras thereof (B). Arrows point to examples of cell membrane staining.

4. Discussion {#sec0090}
=============

Previously we showed that while the S1 domain of the spike of the virulent IBV strain M41 was sufficient for attachment to chicken respiratory tract tissues, the same spike subunit of the embryo-and cell culture adapted Beaudette was unable to bind. We have now demonstrated that this lack of appreciable binding was apparently not due to the absence of attachment factors on host tissue or due to its expression from mammalian cells, but that the combined presence of the S1 and the S2 subunits of the spike ectodomain were essential for attachment. Results of binding experiments using chimeric spike proteins further suggest that the S2 subunit does not contain an additional independent binding site, but rather works together with S1 to acquire binding of the spike to host cells. As only combined S1 and S2 sequences of Beaudette, but not M41, resulted in gain of binding to mammalian cells, this suggests that Beaudette S1 and S2 communicate to establish the first critical step in the extended host tropism of the virus. It might well be that particular sequences in S2 contribute to the higher order structure, stability, or exposure of the receptor binding domain present in the viral attachment protein spike.

Many viruses that have been serially passaged, or isolated from persistently infected cells, have acquired the ability to infect previously non-susceptible cells. For coronaviruses, the extended host range of such viruses has not only been described for IBV ([@bib0150], [@bib0195], [@bib0230]), but also for MHV ([@bib0025], [@bib0020], [@bib0140], [@bib0165], [@bib0180], [@bib0175]). Cells persistently infected with MHV and passaged multiple times generated a virus that gained the ability to enter cells independent of its natural protein receptor CEACAM, but rather use heparan sulfate, explaining their extended cell tropism ([@bib0070]). HS is a well-known co-factor for viral attachment to host cells ([@bib0130]), and has previously been implicated in the extended host range of IBV Beaudette ([@bib0135]). Blocking of Beaudette infection in mammalian cells required, however, rather high concentrations of soluble heparin ([@bib0135]). In our study, we observed no inhibition of attachment of the Beaudette spike to relevant tissues in the presence of soluble heparin as blocking reagent. The lack of involvement of HS in the attachment and the subsequent extended host range of Beaudette is further confirmed upon mutation of the heparin consensus sequence into the corresponding sequence of IBV-M41 with regard to spike binding (this paper) and subsequent entry ([@bib0225]), and the observed enhancing effect of pretreatment of Vero cells with heparinase I on infection (unpublished data cited in [@bib0225]).

Adaptation of IBV strains to embryonated eggs, and in particular Beaudette to Vero cells ([@bib0085], [@bib0185]) is accompanied with accumulating mutations in the spike gene. While it is generally assumed that the RBD of IBV is located in S1, and thus that sequence differences between S1s of Beaudette and M41 contribute to host range, the S1 protein of Beaudette alone was not sufficient for binding to chicken trachea ([@bib0210]), embryonic CAM tissue and mammalian cell lines (this study). Appreciable binding of the Beaudette spike required both the S1 domain and S2 ectodomain, while the extension of M41 S1 with the S2 ectodomain resulted in higher avidity and extended specificity of binding to chicken CAM and trachea tissues. Chimeras showed that both S1 and S2 need to be from the same origin to support the increase in binding ([Fig. 5](#fig0025){ref-type="fig"}B and C) and the extended host range of Beaudette in particular ([Fig. 6](#fig0030){ref-type="fig"}A and B). So while Beaudette and M41 spike ectodomains have over 96% amino acid similarity, likely differences not only in the yet-to-be-mapped RBDs, but also other parts of the spike may affect the binding. Although we cannot completely rule out the presence of an additional attachment site in S2, we believe that the combined presence of S1 and S2 contributes to the attachment, either by altering the stability or the conformation of the spike, resulting in increased binding avidity of the, yet to be identified, RBD in S1. This hypothesis is supported by our unpublished observation that the M41 ectodomain bound to a comparable set of alpha-2,3-sialic acid containing glycans as M41 S1 ([@bib0210]), albeit with a higher avidity. Unfortunately, glycan array analysis for the Beaudette spike ectodomain did not reveal binding to any particular glycan, which might be due to its relatively low avidity in binding compared to M41 ([Fig. 5](#fig0025){ref-type="fig"}B and C). Nevertheless, we clearly demonstrate that attachment of the Beaudette spike ectodomain to host cells requires sialic acids, as binding is precluded when CAM tissue is pretreated with neuraminidase ([Fig. 4](#fig0020){ref-type="fig"}). This is in line with previous reports showing that the embryo- and cell culture adapted IBV strain, like other IBV strains, requires sialic acids for infection ([@bib0005], [@bib0220], [@bib0215]).

In coronavirus infections, when processes of virus attachment and entry cannot be distinguished from each other, a concerted action between S1 and S2 has been observed. For example, the extended host range of MHV strains often requires a combination of mutations in S1 and S2 ([@bib0080], [@bib0145], [@bib0155], [@bib0170], [@bib0200]). When elucidated in more detail, the communication between these regions was particularly contributing to virus-cell fusion and spread of progeny virus. Also for the human coronavirus NL-63, the S2 domain affected the structure and stability of the spike, ultimately required to drive fusion-activating events after binding to the host cell receptor ([@bib0240]). Similarly, for IBV it has been shown that mutations gained during cell passage contributed to increased ability to promote cell-cell fusion ([@bib0230]). In particular, one amino acid change (L857F) converted a non-fusogenic S protein to a fusogenic one, but compensatory mutations in the S1 domain were also required to rescue the cell-cell fusion activity. Our study, however, suggests that S2 not only contributes to virus-cell fusion, but that it might also be crucial for the very first step in virus infection. Whether differences in the metastability of spike ectodomains of Beaudette and M41 account to some extent for the differences in cell tropism, as suggested for MHV ([@bib0080], [@bib0205]), or whether several domains in the spike are required for binding or to form higher order structures to expose the RBD remains to be seen.

Many cellular factors are involved in the subsequent steps of the IBV replication cycle (reviewed in [@bib0245]). After attachment, the virus is internalized and the spike is activated, followed by release of the viral genome in the cytoplasm. Although cleavage of the spike between S1/S2 is not necessary for attachment, it promotes the infectivity of IBV in cells ([@bib0225]). In contrast, the second furin cleavage site in the Beaudette spike is required for furin dependent entry and syncytium formation ([@bib0225]). This correlates with the observation that a productive Beaudette infection is associated with cellular furin abundance in the host cell ([@bib0195]). Interestingly, part of this second furin recognition sequence motif (XXXR/S) is present in many coronaviruses, including M41, and has been proposed to be a common mechanism for entry of coronaviruses into cells ([@bib0225]).

In conclusion, the S1 subunit of IBV Beaudette spike is not sufficient for binding to host tissues, while the full length Beaudette spike ectodomain gained the ability to bind to embryonic and 6-week-old chicken tissues, as well as mammalian cells known to be susceptible to the virus. Based on our current results, we hypothesize that the interplay between the S1 and S2 subunits of spikes from the same viral origin ultimately determine the avidity and specificity of virus attachment and thus viral tropism.
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[^1]: Sequences with ProP scores less than 0.5 are considered not to be cleaved by furin.

[^2]: / indicates site of furin cleavage.

[^3]: [www.cbs.dtu.dk/services/ProP](http://www.cbs.dtu.dk/services/ProP){#intr0005}.
